Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.5.0.2
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Segment Reporting Information [Line Items]          
Revenue from services $ 259,025 $ 103,919 $ 777,559 $ 107,929  
Product revenues 20,569 20,765 63,275 59,066  
Revenue from transfer of intellectual property and other 18,441 18,350 105,338 48,552  
Operating income (loss) (23,623) (8,223) (22,875) (90,547)  
Depreciation and amortization 25,832 12,399 72,612 20,073  
Net income (loss) from investment in investees (814) (3,502) (5,147) (6,067)  
Revenues 298,035 143,034 946,172 215,547  
Assets 2,800,027   2,800,027   $ 2,799,188
Goodwill 700,526   700,526   743,348
United States          
Segment Reporting Information [Line Items]          
Revenues 259,221 104,358 777,703 109,359  
Ireland          
Segment Reporting Information [Line Items]          
Revenues 20,594 22,308 114,526 53,807  
Chile          
Segment Reporting Information [Line Items]          
Revenues 9,936 7,779 26,516 22,929  
Spain          
Segment Reporting Information [Line Items]          
Revenues 3,910 3,447 12,257 12,303  
Israel          
Segment Reporting Information [Line Items]          
Revenues 3,699 4,154 12,862 14,309  
Mexico          
Segment Reporting Information [Line Items]          
Revenues 675 988 2,308 2,840  
Corporate          
Segment Reporting Information [Line Items]          
Revenue from services 0 20 0 140  
Revenue from transfer of intellectual property and other 0 0 0 0  
Operating income (loss) (8,128) (11,562) (49,414) (34,444)  
Depreciation and amortization 20 22 60 68  
Net income (loss) from investment in investees 0 0 0 0  
Assets 68,924   68,924   143,402
Goodwill 0   0   0
Segment Reconciling Items          
Segment Reporting Information [Line Items]          
Operating income (loss) 0 0 0 (1,281)  
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Revenue from services 0 160 0 192  
Product revenues 20,569 20,765 63,275 59,066  
Revenue from transfer of intellectual property and other 18,441 18,350 105,338 48,552  
Operating income (loss) (18,593) 5,300 15,422 (36,861)  
Depreciation and amortization 6,994 2,775 12,841 6,902  
Net income (loss) from investment in investees 399 (3,502) (5,643) (6,067)  
Assets 1,318,377   1,318,377   1,234,752
Goodwill 257,570   257,570   251,225
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Revenue from services 259,025 103,739 777,559 107,597  
Revenue from transfer of intellectual property and other 0 0 0 0  
Operating income (loss) 3,098 (1,961) 11,117 (17,961)  
Depreciation and amortization 18,818 9,602 59,711 13,103  
Net income (loss) from investment in investees (1,213) $ 0 496 $ 0  
Assets 1,412,726   1,412,726   1,421,034
Goodwill $ 442,956   $ 442,956   $ 492,123